Clinical trials
Phase 1 trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
106 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 11 |
| 2021 | 12 |
| 2022 | 14 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 9 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Recruiting | 24 |
| Unknown status | 12 |
| Active, not recruiting | 9 |
| Terminated | 6 |
| Enrolling by invitation | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respirent Pharmaceuticals Co Ltd. | 16 |
| The Foundation for Orthopaedics and Regenerative Medicine | 15 |
| Amgen | 7 |
| Hoffmann-La Roche | 5 |
| Biogenea Pharmaceuticals Ltd. | 4 |
| Hellenic Anticancer Society | 3 |
| Merck Sharp & Dohme LLC | 3 |
| University of Ioannina | 3 |
| University of Thessaly | 3 |
| Aristotle University Of Thessaloniki | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 9 |
| Neoplasms | 9 |
| Asthma | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Recurrence | 4 |
| Cerebral Palsy | 3 |
| Myelodysplastic Syndromes | 3 |
Trials
Showing 51 to 75 of 106. Each trial links to its page on Pharma Observatory.
6 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.